← Back to Clinical Trials
Recruiting NCT07060131

Observe the Effects of Far Infrared Eye Masks on Acupoints Around the Eyes in Patients With Dry Eye Syndrome

Trial Parameters

Condition Dry Eye Disease (DED)
Sponsor China Medical University Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 45
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2024-03-21
Completion 2026-03-31
Interventions
Far Infrared Eye Masks

Brief Summary

Dry eye disease (DED) is a multifactorial ocular surface condition characterized by instability of the tear film. DED is common in ophthalmic and optometric clinical practice, and meibomian gland dysfunction (MGD) has been identified as a major cause of evaporative DED. The use of heated eye mask is a common recommendation in the treatment of MGD, aiming to adequately heat the meibum to increase its liquefaction and flow. Several products are available for this purpose (e.g., Bruder Moist Heat Eye Compress \[Bruder Healthcare Company\], EyeGiene® \[Eyedetec Medical\], Blepha EyeBag® \[formerly MGDRx EyeBag, Théa Pharmaceuticals Ltd\], Blephasteam® \[Théa Pharmaceuticals Ltd\]). This study employs far-infrared eye masks on the acupoints around the eyes, including Jingming, Taiyang, Sibai, Tongziliao, and Si Zhu Kong to assess whether there is an improvement in the symptomatic indicators of dry eye disease.

Eligibility Criteria

Inclusion Criteria: \*Clinical diagnosis of Dry Eye Disease by Ocular Surface Disease Index (OSDI) ≥ 13 and NIBUT \<10 seconds. Exclusion Criteria: * Eye inflammation * Eyelid malposition, such as entropion, ectropion, and upper eyelid ptosis * Recent eye surgery (within 3 months) * Risks of retinal detachment such as high myopia, lattice degeneration, and retinal holes * Use anti-inflammatory eye drops (topical steroids or cyclosporine) within 1 month

Related Trials